Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Liver ; 21(3): 183-91, 2001 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-11422781

RESUMO

BACKGROUND/AIMS: Idoxifene is a tissue-specific selective estrogen receptor modulator. Estradiol is a potent endogenous antioxidant, and nuclear factor kappaB (NF-kappaB) is a key transcription factor that induces multiple genes in response to inflammation or oxidative stress. The aim of this study was to explore the inhibitory effects of idoxifene and estradiol on NF-kappaB activation in hepatocytes in a state of oxidative stress. METHODS: Lipid peroxidation was induced in cultured rat hepatocytes by incubation with ferric nitrilotriacetate solution. NF-kappaB activity was evaluated by electrophoretic mobility shift assay. RESULTS: The oxidative stress-induced activation of NF-kappaB and degradation of IkappaB-alpha were maximal at 3-5 h, with an increase in lactate dehydrogenase (LDH) and malondialdehyde (MDA) secretion into the culture medium. Treatment with idoxifene and estradiol inhibited IkappaB-alpha degradation and NF-kappaB activation through the attenuation of hepatocyte oxidative bursts and decreased extracellular levels of LDH and MDA. In addition, idoxifene and estradiol inhibited lipid peroxidation in rat liver mitochondria. A potent NF-kappaB inhibitor, pyrrolidine dithiocarbamate, prevented NF-kappaB activation by inhibition of IkappaB-alpha degradation and decreased LDH and MDA levels, suggesting that NF-kappaB might be a regulator in a genetic response to increase oxidative stress-induced hepatic injury. CONCLUSIONS: These findings suggest that idoxifene and estradiol function as antioxidants and protect hepatocytes from inflammatory cell injury.


Assuntos
Estradiol/farmacologia , Antagonistas de Estrogênios/farmacologia , Hepatócitos/efeitos dos fármacos , NF-kappa B/biossíntese , Estresse Oxidativo , Tamoxifeno/farmacologia , Animais , Antioxidantes/farmacologia , Western Blotting , Células Cultivadas , Meios de Cultura/química , Relação Dose-Resposta a Droga , Hepatócitos/metabolismo , L-Lactato Desidrogenase/antagonistas & inibidores , L-Lactato Desidrogenase/metabolismo , Peroxidação de Lipídeos/efeitos dos fármacos , Masculino , Malondialdeído/antagonistas & inibidores , Malondialdeído/metabolismo , Microscopia Confocal , Mitocôndrias Hepáticas/efeitos dos fármacos , Mitocôndrias Hepáticas/enzimologia , NF-kappa B/análise , NF-kappa B/antagonistas & inibidores , Pirrolidinas/farmacologia , Ratos , Ratos Wistar , Tamoxifeno/análogos & derivados , Tiocarbamatos/farmacologia , Fatores de Tempo
2.
Intern Med ; 40(2): 100-4, 2001 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-11300139

RESUMO

We report an 18-year-old male patient who developed chronic hepatitis C after blood transfusion and had testicular dysfunction after irradiation for a testicular relapse of childhood acute lymphocytic leukemia after cessation of maintenance therapy, and the initiation of testosterone replacement therapy at puberty. Concomitant administration of estradiol resulted in a reduction in serum alanine aminotransferase and ferritin levels and hepatic iron concentration and staining after 2 years of estrogen therapy, although interferon therapy was withdrawn because of adverse effects. This observation suggests that endogenous estradiol may play a beneficial role in male patients with chronic hepatitis C.


Assuntos
Estradiol/análogos & derivados , Estradiol/uso terapêutico , Terapia de Reposição de Estrogênios , Hepatite C Crônica/tratamento farmacológico , Hipogonadismo/etiologia , Lesões por Radiação/etiologia , Radioterapia/efeitos adversos , Doenças Testiculares/etiologia , Testosterona/análogos & derivados , Adolescente , Alanina Transaminase/sangue , Antivirais/uso terapêutico , Biópsia , Colágeno/análise , Terapia Combinada , Estradiol/deficiência , Estradiol/fisiologia , Ferritinas/análise , Hormônio Foliculoestimulante/sangue , Hepatite C Crônica/sangue , Terapia de Reposição Hormonal , Humanos , Hipogonadismo/tratamento farmacológico , Hipogonadismo/metabolismo , Interferon alfa-2 , Interferon-alfa/uso terapêutico , Ferro/análise , Infiltração Leucêmica/radioterapia , Fígado/química , Fígado/patologia , Hormônio Luteinizante/sangue , Masculino , Leucemia-Linfoma Linfoblástico de Células Precursoras/tratamento farmacológico , Leucemia-Linfoma Linfoblástico de Células Precursoras/radioterapia , Proteínas Recombinantes , Doenças Testiculares/tratamento farmacológico , Doenças Testiculares/metabolismo , Testículo/patologia , Testículo/efeitos da radiação , Testosterona/deficiência , Testosterona/uso terapêutico , Carga Viral
3.
J Gastroenterol Hepatol ; 16(2): 196-201, 2001 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-11207901

RESUMO

BACKGROUND: It has been reported that chronic infection with hepatitis C virus is associated with excess iron deposits in the liver of subjects who are neither alcoholics nor recipients of blood transfusions. However, little is known about the relationship between hepatic iron concentration (HIC) and the serum levels of hepatic fibrogenesis markers, which were caused by interferon therapy for chronic hepatitis C. Therefore, changes in the serum amino-terminal propeptide of type III procollagen (P-III-P) and the 7S domain of type IV collagen (7S-IV) in 16 patients treated with alpha-interferon (IFN-alpha) were studied, and their HIC and histological assessment evaluated. Hepatic iron concentrations were measured by using liver biopsy specimens obtained before and 6 months after the cessation of treatment. METHODS AND RESULTS: Eight subjects (50%) who had normal alanine transaminase levels at 6 months after therapy showed significantly lowered HIC, and attenuated hepatic iron staining with decreased serum levels of P-III-P and 7S-IV compared to the remaining subjects. The HIC was significantly correlated with the serum levels of P-III-P and 7S-IV in all subjects. CONCLUSIONS: These findings suggest that IFN-alpha treatment may decrease stimuli for fibrogenesis, at least in part, by reducing the hepatic iron deposition in patients with chronic hepatitis C.


Assuntos
Colágeno/sangue , Hepatite C Crônica/tratamento farmacológico , Interferon-alfa/uso terapêutico , Ferro/análise , Fígado/química , Pró-Colágeno/sangue , Adulto , Feminino , Humanos , Ácido Hialurônico/sangue , Masculino , Pessoa de Meia-Idade , Estrutura Terciária de Proteína
4.
J Med Invest ; 47(3-4): 145-7, 2000 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-11019494

RESUMO

We encountered a patient whose blood was sucked by Haemaphysalis longicornis in the suburb of a business city in Tokushima prefecture in Japan. The tick, which had been attached to the lower limb of the patient for one week, measured 10 mm in length. There were no notable objective or subjective findings after the complete extirpation of the tick. The area had not been known in recent history to be a habitat of ticks, and, thus, this case is of importance in terms of predicting future trends of tick-borne diseases in Japan.


Assuntos
Mordeduras e Picadas , Doenças Transmitidas por Carrapatos , Carrapatos , Idoso , Animais , Feminino , Humanos , Japão , Doenças Transmitidas por Carrapatos/prevenção & controle , Doenças Transmitidas por Carrapatos/transmissão
5.
Biochem Mol Biol Int ; 46(5): 1055-61, 1998 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-9861459

RESUMO

To simply and directly evaluate DNA fragmentation during apoptosis induced in mouse cultured hepatocytes by an anti-Fas antibody, we examined the fluorescence intensity in cell nuclei stained with ethidium bromide and 4'-6-diamidino-2-phenylindole by optiphoto fluorescence microscopy. The intensity of the former staining for the nuclear DNA of apoptotic cells was clearly decreased compared to that of non-apoptotic cells, whereas no difference in the fluorescence intensity for the latter stain between the apoptotic and non-apoptotic groups was observed. Thus, the use of optiphoto fluorescence microscopy, in conjunction with both stains, constitutes a useful tool for the evaluation of apoptotic DNA fragmentation.


Assuntos
Apoptose , Fragmentação do DNA , DNA/metabolismo , Etídio/metabolismo , Corantes Fluorescentes/metabolismo , Indóis/metabolismo , Animais , Anticorpos/farmacologia , Núcleo Celular/efeitos dos fármacos , Núcleo Celular/metabolismo , Células Cultivadas , Fragmentação do DNA/efeitos dos fármacos , Dactinomicina/farmacologia , Substâncias Intercalantes/metabolismo , Fígado/citologia , Fígado/efeitos dos fármacos , Masculino , Camundongos , Camundongos Endogâmicos BALB C , Microscopia de Fluorescência , Coloração e Rotulagem , Receptor fas/imunologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...